Abstract
Reduction of mortality and improvement of outcome are the major goals of new therapeutic strategies in acute ischemic stroke. Some subtypes of acute ischemic stroke such as intracranial internal carotid artery (ICA) occlusion, proximal middle cerebral artery (MCA) occlusion, basilar thrombosis, and space-occupying infarcts carry a high mortality of more than 80% in selected cohorts [1,2]. Aggressive approaches to acute ischemic stroke such as thrombolytic therapy, hypervolemic-hypertensive therapy, or decompressive surgery require management in specialized neurological critical care units: computed tomographic (CT) scans, magnetic resonance imaging (MRI), Doppler ultrasound, and electrophysiological and intracranial pressure monitoring device are essential and should be readily available. A 24-h-shift service by neurologists and close collaboration with neurosurgery and neuroradiology are necessary. Another challenge of critical care in acute ischemic stroke is reduction of mortality from cardiovascular complications and nosocomial infections. Mortality within the first 4 weeks after an ischemic stroke is greatly influenced by coexistent cardiovascular disease [3,4]. In total, about 8%–10% of acute stroke victims may require critical care treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hacke W, Zeumer H, Ferbert A, Brückmann H, del Zoppo GJ (1988) Intrarterial firbrinolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 19: 1216–1222
Rieke K, Krieger D, Adams HP, Aschoff A, Meyding-Lamade U, Hacke W (1993) Therapeutic strategies in space-occupying cerebellar infarction based on clinical, neuro-radiological, and neurophysiological data. Cerebrovasc Dis 3: 45–55
Chambers BR, Norris JW, Shurvell BL, Hachinski VC (1987) Prognosis of acute stroke. Neurology 37: 221–225
del Zoppo GJ, Pessin MS, Mori E, Hacke W (1991) Thrombolytic intervention in acute thrombotic and embolic stroke. Semin Neurol 11: 368–384
Britton M, Carlsson A, De Faire U (1986) Blood pressure cause with acute stroke and matched controls. Stroke 17: 861–864
Powers WJ (1993) Acute hypertension after stroke: the scientific basis for treatment decisions. Neurology 43: 461–467
Yatsu FM, Zivin J (1985) Hypertension in acute ischemic strokes. Not to treat. Arch Neurol 42: 999–1000
Hacke W, Krieger D, Hirschberg M (1991) General principles in the treatment of acute ischemic stroke. Cerebrovasc Dis 1: 93–99
Strandgaard S, Paulsen OB (1992) Regulation of cerebral blood flow in health and disease. J Cardiovasc Pharmacol 19 (suppl 6): 89–93
Hayashi M, Kobayashi H, Kawano H, Handa Y, Hirose S (1987) Treatment of systemic hypertension and intracranial hypertension in cases of brain hemorrhage. Stroke 19: 314–321
Brott T, MacCarthey EP (1989) Antihypertensive therapy in stroke. In: Fischer M (ed) Medical therapy of acute stroke. Dekker, New York, pp 117–143
Hacke W, del Zoppo GJ, Furlan AJ, von Kummer R (in press) In: Hanley D (ed) Principles and practice of neurocritical care. Williams and Wilkins, Baltimore
Raichle ME (1983) The pathophysiology of brain ischemia. Ann Neurol 13: 2–10
Toni D, Sacchetti ML, Argentino C, Gentile M, Cavallentti C, Frontoni M, Fieschi C (1992) Does hyperglycemia play a role on the outcome of acute ischaemic stroke patients? J Neurol 239: 382–386
Wagner KR, Kleinholz M, de Courten-Myers GM, Myers RE (1992) Hyperglycemic versus normoglycemic stroke: topography of brain metabolites, intracellular pH, and infarct size. J Cereb Blood Flow Metab 12: 213–222
Awad IA, Carter P, Spetlzer RF, Medina M, Williams FW (1987) Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension. Stroke 18: 365–372
Finn S, Stephensen SA, Miller CA, Drobnich L, Hunt W (1986) Observations on the perioperative management of aneurysmal subarachnoid hemorrhage. J Neurosurg 65: 48–62
Baker RN, Broward JA, Fang HC, Fisher CM, Groch SN, Heyman A (1962) Anticoagulant therapy in cerebral infarction. Neurology 12: 823–835
Carter AB (1961) Anticoagulant treatment in progressing stroke. BMJ 2: 70–73
Haley EC, Kassell NF, Torner JC (1988) Failure of heparin to prevent progression in progressing ischemic infarction. Stroke 19: 10–14
Miller VT, Hart RG (1988) Heparin anticoagulation in acute brain ischemia. Stroke 19: 403–406
Phillips SJ (1989) An alternative view of heparin anticoagulation in acute focal brain ischemia. Stroke 20: 295–298
Scheinberg P (1989) Heparin anticoagulation. Stroke 20: 173–174
von Kummer R, Hacke W (1992) Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke 23: 646–652
del Zoppo GJ, Ferbert A, Otis S, Brückmann H, Hacke W, Zyroff J, Harker L, Zeumer H (1988) Local intraarterial fibrinolytic therapy in acute carotid territory stroke. A pilot study. Stroke 19: 307–313
Mori E, Tabuchi M, Yoshida T, Yamadori A (1988) Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke 19: 802–812
del Zoppo GJ, Furlan A, Hacke W (1990) Treatment of acute stroke. Ann Intern Med 112: 713
Yamaguchi T, Hayakawa T, Kikuchi H (1993) Intravenous tissue plasminogen activator in acute thromboembolic stroke: a placebo-contolled double-blind trial. In: del Zoppo GJ, Mori E Hacke W (eds) Thrombolytic therapy in acute ischemic stroke, II. Springer, Berlin, pp 59–65
Krieger D, Adams H, Rieke K, Schwarz S, Forsting M, Hacke W (1992) Prospective evaluation of the prognostic significance of evoked potentials in acute basilar occlusion. Crit Care Med 21 (8): 1169–1174
Goetting MG, Preston G (1991) Jugular bulb catheterization does not increase intracranial pressure. Intensive Care Med 17: 195–198
Nau R, Dreyhaupt T, Kolenda H, Prange HW (1992) Low blood-to-cerebrospinal fluid passage of sorbitol after intravenous infusion. Stroke 23: 1276–1279
Nau R, Prins FJ, Kolenda H, Prange HW (1992) Temporary reversal of serum to cerebrospinal fluid glycerol concentration gradient after intravenous infusion of glycerol. Eur J Clin Pharmacol 42: 181–185
Bayer AJ, Pathy MS, Newcombe R (1987) Double-blind randomised trial of intravenous glycerol in acute stroke. Lancet 1: 405–408
Frank MS, Nahata MC, Hilty MD (1981) Glycerol: a review of its pharmacology, pharmacokinetics, adverse reactions, and clinical use. Pharmacotherapy 1: 147–160
Wolf AL, Levi L, Marmarou A, Ward JD, Muizelaar PJ, Choi S, Young H, Rigamonti D, Robinson WL (1993) Effect of THAM upon outcome in severe head insury: a randomizad prospective clinical trial. J Neurosurg 78: 54–59
Winer JW, Rosenwasser RH, Jimenez F (1991) Electroencephalographic activity and serum and cerebrospinal fluid pentobarbital levels in determing the therapeutic endpoint during barbiturate coma. Neurosurgery 29: 739–742
Metz S, Slogoff S (1990) Thiopental sodium by single bolus dose compared to infusion for cerebral protection during cardiopulmonary bypass. J Clin Anesth 2: 226–231
Delashaw JB, Broaddus WC, Kassell NF, Haley EC, Penddleto GA, Vollmer DG, Maggio WW, Grady MS (1990) Treatment of right hemispheric cerebral infarction by hemicraniectomy. Stroke 21: 874–881
Greenwood JJ (1968) Acute brain infarctions with high intracranial pressure: surgical indications. Johns Hopkins Med J 122: 254–260
Ivamoto HS, Numoto M, Donaghy R (1974) Surgical decompression for cerebral and cerebellar infarcts. Stroke 5: 365–370
Rieke K, Krieger D, von Kummer R, Aschoff A, Hacke W (in press) Decompressive surgery in space occupying hemispheric infarction. Critical Care Med
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Tokyo
About this paper
Cite this paper
Hacke, W., Spranger, M., Steiner, T. (1995). Neuro-Intensive Care Units and Management of Acute Stroke Patients: Benefits and Limitations. In: Yamaguchi, T., Mori, E., Minematsu, K., del Zoppo, G.J. (eds) Thrombolytic Therapy in Acute Ischemic Stroke III. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68459-6_16
Download citation
DOI: https://doi.org/10.1007/978-4-431-68459-6_16
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-70139-2
Online ISBN: 978-4-431-68459-6
eBook Packages: Springer Book Archive